Home
Welcome: Login | Register
view counter

Category: BiotechSyndicate content

Medical device manufacturers making biotech products.

Another tough quarter for Charles River Labs

August 4, 2010 by MassDevice staff

Already bruised by decision to spike WuXi PharmaTech deal, Charles River Laboratories International Inc. reports weak second-quarter financial results and trims its earnings and revenue forecasts.

CRL logo

The second quarter at Charles River Laboratories International Inc. (NYSE:CRL) was by all accounts disappointing and things may only get worse.

The clinical research organization on Monday said net income during the three months ended June 30 was $14.5 million, down from a $34.2 million profit during the same quarter last year. Revenues also fell, sliding 5.2 percent to $292.1 million. Revenues in the company's pre-clinical segment fell $17.5 million to $125 million, more than overwhelming a $2 million rise for the research models and services division.

BioSphere shareholders expand lawsuit over Merit merger

July 26, 2010 by MassDevice staff

BioSphere Medical Inc. shareholders add the company as a defendant in a lawsuit alleging that the company and its management misled them regarding a planned, $96 million merger with Merit Medical Systems Inc.

BSMD logo

BioSphere Medical Inc. (NSDQ:BSMD) shareholders added to their attempt to block a proposed, $96 million merger with Merit Medical Systems Inc. (NSDQ:MMSI).

In a class action suit, initially brought against the company's board, the shareholders are attempting to get an injunction against the Merit's purchase of BioSphere.

Taris taps new CEO

July 19, 2010 by MassDevice staff

Taris Biomedical names Sarma Duddu as its new president and CEO.

Taris logo

Taris Biomedical hired Sarma Duddu to be its new president and CEO.

The Lexington, Mass.-based durg/device developer said Duddu brings 15 years of pharmaceutical industry experience to the corner office, where he'll start immediately.

Biodel touts results for "smart" insulin tests

July 13, 2010 by MassDevice staff

Biodel says it's gaining ground on the development of a glucose-regulated insulin product after pre-clinical tests on its new insulin candidate BIOD620.

BIOD logo

Biodel Inc. (NSDQ:BIOD) announced the results of pre-clinical tests on its candidate for a diabetes treatment called BIOD620.

The tests indicated that the Danbury, Conn.-based company's insulin product releases the blood-sugar-regulating hormone in response to changing glucose levels.

Histogenics launches clinical trial

July 9, 2010 by MassDevice staff

Histogenics Corp. launches a clinical trial of its NeoCart implant for repairing knee cartilage.

Histogenics logo

Histogenics Corp. launched a Phase III clinical trial of its NeoCart knee cartilage repair implant, designed to help regenerate tissue.

The Waltham, Mass.-based company said the 245-patient study will compare use of the implant with standard microfracture surgery to repair damaged knee cartilage. Microfrature surgery involves drilling small holes in bone to fill the defect with blood clots. The NeoCart device uses neocartilagenous tissue developed from patients' chondrocyte cells, which are integrated into a three-dimensional collagen matrix, according to a press release.

Surmodics inks licensing agreement with Australian pharma firm

July 8, 2010 by MedCity News

SurModics Inc. reaches a deal to license its drug delivery technology to Australian dermatology drug firm Clinuvel Pharmaceuticals Ltd.

MedCity News logo

By Brandon Glenn

SurModics Inc. (NSDQ:SRDX) reached a deal to license its drug delivery technology to an Australian firm that will use it for a skin disorder treatment.

Bio2 adds $1.1 million to its coffers

July 7, 2010 by MassDevice staff

Woburn, Mass.-based biotechnology firm Bio2 Technologies Inc. raises $1.1 million in an equity offering.

Bio2 logo

Bio2 Technologies Inc. raised $1.1 million in an equity offering, according to a regulatory filing.

The Woburn, Mass.-based orthopedic bio-scaffold developer opened the sale June 28, making $2 million in equity available in minimum purchases of $20,000. Eighteen investors had ponied up for the offering as of the July 1 filing.

Support the news, become a MassDevice.com insider
view counter
Free Literature and Charts from Emergo Group
view counter

follow MassDevice on Twitter

Preferred Vendors

Consulting, Legal

National Standards Authority of Ireland
Provides regulatory compliance services

Consulting, Regulatory

Pacific Bridge Medical
Emergo Group, Inc.
Regulatory charts and consulting

Reimbursement, Salesforce Development and Training, Reimbursement

Medical Education Training Associates LLC (META)
Provides a suite of consulting services for medical device companies
Reimbursement Planning, Health Policy Training
Salesforce development and Management training

Communications / PR, Marketing

Seidler Bernstein
Provides marketing and PR services

Publishing, Software / IT, Consulting

Cine-Med Inc.
Produces medical films and publishes continuing education. materials for medical device companies

Machining, Prototype Manufacturing, Design / Engineering

Roush Life Sciences
Provides design and engineering, rapid prototyping, tooling, engineering and manufacturing services for life science companies
A Division of Roush Enterprises

Original Equipment Manufacturer

Admet
Static and Dynamic testing systems for materials, components, and devices. Systems range from 50 grams to 600kN of force capacity in tension, compression, torsion, and more.
Provides grips, fixtures, heating and cooling systems, and fluid baths.

Assay Testing, Other

Instron
Precision testing instrumentation and services for materials, components, and structures in R&D, Quality Control and Production environments.

Plastics / Molded Products, Original Equipment Manufacturer

SMC Ltd. (Scientific Molding Corp.)
Manufactures injection-molded, single-use disposable medical devices

Legal

Greenberg Traurig LLP
Provides legal services
McClellan Automation Systems
Manufactures custom automated systems and special process machinery

Top News Stories

Quidel gains FDA clearance for pregnancy test
Ex-FDA commissioner joins board of Michigan cancer treatment firm
FDA releases July 510(k) clearances
Feds indict former Spectranetics execs
Lawsuits allege DePuy Orthopedics knew of ASR hip implant defects
InfraReDx wins FDA clearance for coronary imaging system
Orthopedic incubator Excelen inks deal with Twin Star Medical
GI Dynamics inks UK distribution deal
Helicos slaps Pacific Biosciences with patent infringement suit
QED wins Inc. cred
more

RECENT BLOG POSTS

more
Help keep the news free. Support the news. Become a MassDevice.com insider
view counter
view counter
view counter
Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp